Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals-Reference-Cited by-同舟云学术

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals

Published:2017-09-26 Issue:10 Volume:32 Page:1754-1762
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Yeh Ming-Lun¹²³,Huang Chung-Feng²³,Hsieh Meng-Hsuan²³⁴,Ko Yu-Min²,Chen Kuan-Yu²,Liu Ta-Wei²,Lin Yi-Hung²,Liang Po-Cheng²,Hsieh Ming-Yen²,Lin Zu-Yau²³,Chen Shinn-Cherng²³,Huang Ching-I²,Huang Jee-Fu²³⁵,Kuo Po-Lin¹,Dai Chia-Yen¹²³⁵⁴,Yu Ming-Lung²³⁵⁶⁷^ORCID,Chuang Wan-Long²³⁵

Affiliation:

1. Graduate Institute of Medicine, College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

2. Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

3. School of Medicine, College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

4. Health Management Center; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

5. Lipid Science and Aging Research Center, and Center for Infectious Disease and Cancer Research; Kaohsiung Medical University; Kaohsiung Taiwan

6. Institute of Biomedical Sciences; National Sun Yat-Sen University; Kaohsiung Taiwan

7. Liver Center, Division of Gastroenterology, Massachusetts General Hospital; Harvard Medical School; Boston Massachusetts USA

Funder

Kaohsiung Medical University Hospital

Ministry of Science and Technology, R.O.C

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13771/fullpdf

Reference42 articles.

1. Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy;Banerjee;Aliment. Pharmacol. Ther.,2016

2. From non-A, non-B hepatitis to hepatitis C virus cure;Pawlotsky;J. Hepatol.,2015

3. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N. Engl. J. Med.,2014

4. ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV;Ferenci;N. Engl. J. Med.,2014

5. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;Jacobson;N. Engl. J. Med.,2013

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection;Egyptian Liver Journal;2023-06-28

2. Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2022-11-26

3. Hepatitis B Reactivation Following Eradication of HCV with Direct-Acting Antiviral Drugs (DAAs) in a Cohort of Patients from Different Institutions in Egypt;Journal of Clinical and Experimental Hepatology;2022-09

4. Revolution in the diagnosis and management of hepatitis C virus infection in current era;World Journal of Hepatology;2022-04-27

5. Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center;Current Medical Research and Opinion;2022-02-15